Search

Series:

Clinical Minute Retina

The History of ILM Staining

Ramin Tadayoni MD, PhD; and Kazuaki Kadonosono, MD, PhD

Show Description +

Staining the ILM is routine in contemporary vitreoretinal surgery. How did the field arrive at this innovation, and what did the earliest data look like? On this episode of Clinical Minute: Retina, Ramin Tadayoni, MD, PhD, invites Kazuaki Kadonosono, MD, to share his experiences with the earliest days of ILM staining. How did Prof. Kadonosono and his team formulate a safe and effective staining agent, and how did they build on findings from anterior segment surgeons to move retina forward?

Posted: 4/26/2022

Keywords:

internal limiting membrane (ILM)

•

Staining

Up Next

Phase 3 Faricimab Data and the Dawn of a New Molecule

Phase 3 Faricimab Data and the Dawn of a New Molecule

Ramin Tadayoni, MD, PhD and Charles Wykoff, MD, PhD

GATHER2 Data at 1 and 2 Years

GATHER2 Data at 1 and 2 Years

Ramin Tadayoni, MD, PhD and Arshad Khanani, MD, MA

Response to Protocol V: Is Observation a Wise Approach to DME with 20/25 Vision?

Response to Protocol V: Is Observation a Wise Approach to DME with 20/25 Vision?

Diana Do, MD, and Ramin Tadayoni, MD, PhD

Baseline Characteristics and Response to Intravitreal Dexamethasone Implant in DME

Baseline Characteristics and Response to Intravitreal Dexamethasone Implant in DME

Patricia Udaondo, MD, PhD and Ramin Tadayoni, MD, PhD

Biosimilars in Retina

Biosimilars in Retina

Ramin Tadayoni, MD, PhD, and Prof. Frank Holz

Meta-analysis of Anti-VEGF Agents in Wet AMD Therapy

Meta-analysis of Anti-VEGF Agents in Wet AMD Therapy

Ramin Tadayoni, MD, PhD and Jean-Francois Korobelnik, MD, PhD

PPV vs Conventional Therapy for PDR

PPV vs Conventional Therapy for PDR

María H. Berrocal, MD, and Ramin Tadayoni, MD, PhD

ALOFT Study: Value of False Positive Alerts in Home Monitoring for Wet AMD Conversion

ALOFT Study: Value of False Positive Alerts in Home Monitoring for Wet AMD Conversion

Ramin Tadayoni, MD, PhD, and Allen C. Ho, MD

GA Therapy After the Newest DERBY/OAKS Data

GA Therapy After the Newest DERBY/OAKS Data

Eleonora Lad, MD, PhD and Ramin Tadayoni, MD, PhD

Protocol AC: Step Therapy in DME

Protocol AC: Step Therapy in DME

Chirag D. Jhaveri, MD; and Prof. Ramin Tadayoni

TRUCKEE Study Data

TRUCKEE Study Data

Ramin Tadayoni, MD, PhD and Arshad Khanani, MD, MA

Pegcetacoplan Phase 3 Data

Pegcetacoplan Phase 3 Data

Ramin Tadayoni, MD, PhD and Caroline Baumal, MD

Rates of Endophthalmitis in a Nationwide Study

Rates of Endophthalmitis in a Nationwide Study

Ramin Tadayoni, MD, PhD; and Catherine Creuzot-Garcher, MD

Why Some Clinical Trials Succeed Where Others Do Not

Why Some Clinical Trials Succeed Where Others Do Not

Ramin Tadayoni, MD, PhD; and Peter Kaiser, MD

AI in Retinal Imaging

AI in Retinal Imaging

Ramin Tadayoni, MD, PhD; Ursula Schmidt-Erfurth, MD

Intraoperative OCT: From Concept to Execution

Intraoperative OCT: From Concept to Execution

Ramin Tadayoni, MD, PhD; and Cynthia Toth, MD

AI in the Modern Age of Retina

AI in the Modern Age of Retina

Anat Loewenstein MD, MHA

Back to All Videos

The History of ILM Staining

Ramin Tadayoni MD, PhD; and Kazuaki Kadonosono, MD, PhD

Staining the ILM is routine in contemporary vitreoretinal surgery. How did the field arrive at this innovation, and what did the earliest data look like? On this episode of Clinical Minute: Retina, Ramin Tadayoni, MD, PhD, invites Kazuaki Kadonosono, MD, to share his experiences with the earliest days of ILM staining. How did Prof. Kadonosono and his team formulate a safe and effective staining agent, and how did they build on findings from anterior segment surgeons to move retina forward?

Posted: 4/26/2022

Keywords:

internal limiting membrane (ILM)

•

Staining

Please log in to leave a comment.